Table 2. Excipient-target activities determined in vitro.
Excipient | Function | Structure | Example marketed drug | Highest excipient amount/dose | Target | Ki/IC50 Or EC50 (μM) |
---|---|---|---|---|---|---|
Aspartame | Sweetener | Purixan | 450 mg† | NR1I2 | 13 | |
Benzethonium chloride | Antimicrobial preservative; antiseptic; disinfectant | Ketalar/ketamine hydrochloride§ | 0.1%‡ | ADORA3 ADRA1A DRD1 DRD3 ESR1 HRH3 PRG OPRM PDE4D PTGS2 ABCB11 SLC18A2 KCNH2 |
5.3 4.7 3.8 1.6 11 27 6.2 6.0 14 24 29 0.18 1.9 |
|
Benzoic acid | Antimicrobial preservative; therapeutic agent | Excedrin Migraine | 25 mg/5 ml† |
ABCB11 SLC18A2 |
260 18 |
|
Butylparaben | Antimicrobial preservative | Fexofenadine (children’s allergy) | 8 mg/5 ml† |
SLCO2B1 ADRA1A SLC6A2 SLC6A3 TBXA2R SLC18A2 SCN5A |
39 16 20 18 19 6.6 33 |
|
Cetylpyridinium chloride | Antimicrobial preservative; antiseptic; surfactant; disinfectant; solubilizer; wetting agent | Dyazide | 1.5 mg† |
ADRA1A DRD1 DRD3 ESR1 HRH3 PRG OPRM1 PDE4D PTGS1 PTGS2 TBXA2R SLC18A2 KCNH2 SCN5A |
6.4 4.8 0.55 18 13 4.5 5.1 13 7.5 2.5 3.4 0.73 1.3 34 |
|
Chloroxylenol | Antimicrobial preservative; antiseptic; disinfectant | Miconazole nitrate | 0.1%‡ |
CHRM1 ADRA1A SLC18A2 |
9.9 14 0.79 |
|
Cysteine | Antioxidant* | Zyban | 16.2 mg† | PTGS2 | 4.7 | |
D&C Red No. 28 | Colorant | Nexium 24HR | 2.5 mg/5 ml† |
SLCO2B1 ADRA1A DRD1 ADORA3 CHRM2 OPRM1 PDE3A PDE4D |
0.60 0.48 0.59 0.48 0.68 0.82 0.13 0.94 |
|
Ethylparaben | Antimicrobial preservative | Clindamycin (pediatric) | 2 mg/5 ml† | SLC18A2 | 22 | |
FD&C Red No. 3 | Colorant | Esomeprazole | 2 mg/5 ml† | ACHE PDE3A PDE4D |
0.42 0.092 0.32 |
|
FD&C Yellow No. 5 (Tartrazine) | Colorant | Pepcid Complete (tropical flavor) | 652 mg† | DRD1 OPRM1 GABRA1 |
23 16 13 |
|
Methylene Blue | Colorant | Diurex Water Pills† | 1%§ | ACHE CHRM2 HRH3 KCNH2 |
0.090 0.19 0.88 27.5 |
|
Oleic acid | Emulsifying agent; skin penetrant | Verapamil | 598.6 mg† |
PTGS1 PTGS2 SLC18A2 |
6.7 3.5 4.7 |
|
Palmitic acid | Emulsifying agent; skin penetrant; tablet and capsule lubricant | Captopril | 6 mg† |
PDE3A PDE4D SLC18A2 |
4.1 6.6 4.4 |
|
Phenylmercuric acetate | Antimicrobial preservative; antiseptic | - | 0.01%¶ | DRD1 DRD3 SLC6A2 SLC6A3 CHRM1** SLC18A2 KCNH2 |
2.2 0.024 1.7 1.8 8.1 0.36 6.2 |
|
Propyl gallate | Antioxidant | Janumet XR | 2 mg† |
ALOX5 PTGS2 TY3H KDM4C FTO |
0.43 7.2 1.9 39 3.0 |
|
Propylparaben | Antimicrobial preservative | Keppra | 200 mg/5 ml† |
SLC6A2 KDR LTA4H |
30 24 260 |
|
Sodium lauryl sulfate | Anionic surfactant; detergent; emulsifying agent; skin penetrant; lubricant; wetting agent | Cetirizine | 96 mg† | HTR1A ADORA3 CHRM1 ADRA1A DRD3 PRG PDE4D |
15 15 29 15 18 15 23 |
|
Stearic acid | Emulsifying agent; solubilizing agent; tablet and capsule lubricant | Kariva | 1203 mg/5 ml† |
PDE3A PDE4D |
3.1 6.7 |
|
Thimerosal | Antimicrobial preservative; antiseptic | Influenza vaccines multidose packaging | 0.03%§ | ADORA3 ADRA2A SLC18A2 DRD1 DRD3 5HT2b** |
1.6 3.8 0.97 2.4 0.32 15 |
|
Ethyl mercury | Thimerosal major metabolite | NA | NA | DRD3 DRD5 |
0.21 0.15 |
|
Thymol | Antioxidant; antiseptic; cooling agent; disinfectant; flavoring agent; skin penetrant | Listerine† | 0.01%# |
CHRM1 ADRA1A SLC6A2 SLC18A2 |
14 26 28 25 |
From (65).
Oral.
Auricular.
Intravenous.
Topical.
Inhalation.
An agonist effect was observed.